Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Structural and theoretical exploration of a multi-methoxy chalcone: Synthesis, quantum theory, electrostatics, molecular packing, DFT analysis, and in-silico anti-cancer evaluation.
Al-Ostoot FH, Akhileshwari P, Kameshwar VH, Geetha DV, Aljohani MS, Alharbi HY, Khanum SA, Sridhar MA. Al-Ostoot FH, et al. Among authors: aljohani ms. Heliyon. 2024 Jul 2;10(13):e33814. doi: 10.1016/j.heliyon.2024.e33814. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39055829 Free PMC article.
Synthesis, crystal structure, DFT, Hirshfeld surface analysis, energy frameworks and in-Silico drug-targeting PFKFB3 kinase of novel triazolequinoxalin derivative (TZQ) as a therapeutic Strategy against cancer.
Abad N, Al-Ostoot FH, Ashraf S, Chkirate K, Aljohani MS, Alharbi HY, Buhlak S, El Hafi M, Van Meervelt L, Al-Maswari BM, Essassi EM, Ramli Y. Abad N, et al. Among authors: aljohani ms. Heliyon. 2023 Oct 20;9(11):e21312. doi: 10.1016/j.heliyon.2023.e21312. eCollection 2023 Nov. Heliyon. 2023. PMID: 37920528 Free PMC article.
Design, synthesis, docking, ADMET and anticancer evaluations of N-alkyl substituted iodoquinazoline derivatives as dual VEGFR-2 and EGFR inhibitors.
Alsulaimany M, El-Adl K, Aljohani AKB, Alharbi HY, Alatawi OM, Aljohani MS, El-Morsy A, Almadani SA, Alsimaree AA, Salama SA, Keshek DE, Mohamed AA. Alsulaimany M, et al. Among authors: aljohani ms, aljohani akb. RSC Adv. 2023 Dec 13;13(51):36301-36321. doi: 10.1039/d3ra07700d. eCollection 2023 Dec 8. RSC Adv. 2023. PMID: 38093733 Free PMC article.
Anticancer evaluations of iodoquinazoline substituted with allyl and/or benzyl as dual inhibitors of EGFRWT and EGFRT790M: design, synthesis, ADMET and molecular docking.
Aljohani AKB, El-Adl K, Almohaywi B, Alatawi OM, Alsulaimany M, El-Morsy A, Almadani SA, Alharbi HY, Aljohani MS, Abdulhaleem M FA, Osman HEM, Mohamady S. Aljohani AKB, et al. Among authors: aljohani ms. RSC Adv. 2024 Mar 6;14(12):7964-7980. doi: 10.1039/d4ra00502c. eCollection 2024 Mar 6. RSC Adv. 2024. PMID: 38454937 Free PMC article.
33 results